Tumor response evaluation criteria for HCC (hepatocellular carcinoma) treated using TACE (transcatheter arterial chemoembolization): RECIST (response evaluation criteria in solid tumors) version 1.1 and mRECIST (modified RECIST): JIVROSG-0602

Author： Sato Yozo  

Publisher： Informa Healthcare

ISSN： 0300-9734

Source： Upsala Journal of Medical Sciences, Vol.118, Iss.1, 2013-03, pp. : 16-22

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Response Evaluation Criteria in Solid Tumors (RECIST) following neoadjuvant chemotherapy in osteosarcoma

By  

PEDIATRIC BLOOD & CANCER (ELECTRONIC), Vol. 65, Iss. 4, 2018-04 ,pp. : n/a-n/a

John Wiley & Sons Inc

Access to resources Recommend Favorite

Early Prediction of the Outcome Using Tumor Markers and mRECIST in Unresectable Hepatocellular Carcinoma Patients Who Underwent Transarterial Chemoembolization

By  

Oncology, Vol. 91, Iss. 6, 2016-10 ,pp. : 317-330

Karger

Access to resources Recommend Favorite

Reproducibility of mRECIST in assessing response to transarterial radioembolization therapy in hepatocellular carcinoma

By  

HEPATOLOGY, Vol. 270-9139, Iss. 4, 2015-10 ,pp. : 1111-1121

John Wiley & Sons Inc

Access to resources Recommend Favorite

Reproducibility of mRECIST in assessing response to transarterial radioembolization therapy in hepatocellular carcinoma

By  

HEPATOLOGY, Vol. 62, Iss. 4, 2015-10 ,pp. : 1111-1121

John Wiley & Sons Inc

Access to resources Recommend Favorite

Evaluation of the mRECIST and α-Fetoprotein Ratio for Stratification of the Prognosis of Advanced-Hepatocellular-Carcinoma Patients Treated with Sorafenib

By  

Oncology, Vol. 83, Iss. 4, 2012-08 ,pp. : 192-200

Karger

Access to resources Recommend Favorite